课题基金 / 基金详情

Production of eCD4-IG protein

Production of eCD4-IG protein
eCD4-IG 蛋白的生产
批准号：
10020277
负责人：
THOMAS VANCOTT
金额：
$19.89万
依托单位：
ADVANCED BIOSCIENCE LABORATORIES, INC.
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
项目状态：
已结题
起止时间：
2015-09-18 至 2022-12-31
来源：
https://reporter.nih.gov/project-details/10020277
关键词：
ContractsDevelopmentDocumentationHIV-1Investigational DrugsInvestigator-Initiated ResearchNational Institute of Allergy and Infectious DiseasePhasePreclinical TestingProductionProteinsflexibilityinhibitor/antagonistpreclinical developmentresearch clinical testingresearch study

项目摘要

项目成果

THOMAS VANCOTT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This contract will provide NIAID with a broad and flexible range of nontraditional, proactive and developmentally-oriented capabilities to provide preclinical development for promising products for when such products emerge from investigator-initiated research studies. These capabilities will allow NIAID to more rapidly and efficiently close development and production gaps. Activities will include but not limited to small-scale production, preclinical testing and documentation leading to Investigational New Drug (IND) submission for Phase I, II, and III clinical testing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Essential Core Activities: NIAID Preclinical Development Support
NIAID Preclinical Development Support: Adjuvants for HIV-1 Vaccines
ESSENTIAL CORE ACTIVITIES, NIAID PRECLIN DEVELOPMENT SUPPORT
Essential Core Activities: NIAID Preclinical Development Support
国内基金
海外基金
水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
  • 批准号：
    --
  • 项目类别：
    --
  • 资助金额：
    40万元
  • 批准年份：
    2020
  • 负责人：
    Vikrant Gupta
  • 依托单位：
    南方科技大学